NovaBone Products, LLC has announced the relocation of its operations
division to expanded and upgraded facilities where it will meet
increasing demands of higher sales to a more geographically diverse
distributor network.
“The manufacturing area is double that of our previous facility”
NovaBone Products is a privately-held company and a leader in developing
bio-engineered bone graft substitutes to meet the specialized demands of
orthopedic and dental surgeons.
Located in the Progress Corporate Park in Alachua, Florida, the new
facility has been effectively designed to facilitate the needs of a
growing medical-device company. More than twice the size of the former
operations location, the new facility increases productivity for both
manufacturing and management functions.
Designed to meet the same ISO 13485 certifications as the prior
relocation, the move was completed without disruption of service.
An updated product storage area was specifically constructed with
mechanisms that satisfy a comprehensive disaster prevention system, as
well as NovaBone’s enhanced security measures. The area further improves
inventory handling, including shipment to customers.
“The manufacturing area is double that of our previous facility,” cites
David Gaisser, Vice President of Operations. “This provides for an
improved product flow and more efficient production.”
Established in 2002, NovaBone Products develops bone graft substitutes
based on advancements in biomedical engineering.
Since its inception, NovaBone has developed numerous formulations and
delivery systems of its patented, bioactive technology platform that
result in accelerated bone growth. In total, the company’s exclusively
formulated bone graft substitute has been used for the repair of osseous
defects throughout the skeletal system for over a decade in more than a
million clinical applications with unparalleled success validating the
safety and efficacy of NovaBone's technology.